EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles

Fei Shen, Yun-Sheng Zheng, Lan Dong, Ziyang Cao, Jie Cao

Frontiers in Pharmacology · 01.11.2024 · 15

DOI: 10.3389/fphar.2024.1500731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.11.2024. Verfasst von Fei Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) stands as the third most widespread cancer globally with poor prognosis. Berberine (Ber), as one herbal phytochemical, showed promise in CRC therapy, but its exact mechanism is unclear. Small molecule traditional drugs face challenges in quick metabolism and low bio-availability after systemic administration. Nanodrug deliver system, with their unique properties, has the advantages of protecting drugs, improving drug bio-availability, and reducing toxic and side effects, which exhibited huge drug delivery potential. Herein, the PEG-PLGA nanocarrier was used for encapsulated Ber according to nanoprecipitation and obtained nanomedicine, denoted as NPBer. In vitro , the flow cytometry test and CCK8 assays indicated that NPBer was more easily taken up by HCT116 CRC cells, and had stronger inhibition on cell proliferation with the increase of drug concentration. In addition, RNA-Seq was employed to explore the alterations in the transcriptomes of cancer cells subsequent to treatment with Free Ber or NPBer.The sequencing results indicate that Free Ber could activate cellular aging mechanisms, intensified the iron death pathway, optimized oxidative phosphorylation efficiency, exacerbated apoptosis, accelerated programmed cell death, and negatively modulated key signaling pathways in CRC cells including Wnt, TGF-beta, Hippo, and mTOR signaling pathways. Based on PEG-PLGA nanocarriers, NPBer can improve the in vivo delivery efficiency of Ber, thereby enhancing its antitumor efficacy in vivo , enhancing apoptosis by enhancing the mitochondrial autophagy and autophagy activities of CRC cells, negatively regulating the inflammatory mediator to regulate TRP channels, and inhibiting the activation of Notch signaling pathway. In vivo , NPBer can significantly improve its accumulation and durable drug targeting in tumor site, resulting in induce maximum cell apoptosis and effectively inhibit the proliferation of HCT116 tumor. This strategy provided a promising antitumor therapeutic strategy using Ber-based drugs.

Schlagwörter

Stichwörter der Autor:innen

RNA-seqberberinecolorectal cancernanocarriersignaling pathways

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Department of General Surgery, Guangzhou Digestive Disease Center, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

Zitieren

APA

Shen, F., Zheng, Y. S., Dong, L., Cao, Z., & Cao, J. (2024). Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1500731

Vancouver

Shen F, Zheng YS, Dong L, Cao Z, Cao J. Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1500731

BibTeX
@article{Shen2024,
  author = {Shen, Fei and Zheng, Yun-Sheng and Dong, Lan and Cao, Ziyang and Cao, Jie},
  title = {Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1500731}
}
Kostenlos starten →